China National Pharmaceutical Group: The accumulated repurchase of shares accounts for 1.07% of the total share capital, with a total amount of 131 million yuan.

Guobang Pharm announced that, as of June 24, 2026, the company has repurchased a total of 8.4016 million shares, accounting for 1.07% of the total share capital, an increase of 0.25% since the last disclosure. The repurchase price range is 14.99 yuan/share - 16.14 yuan/share, with a total amount paid of 131 million yuan. This repurchase is used for employee stock ownership plans or equity incentives, with an estimated repurchase amount of 100 million yuan to 200 million yuan, with a term from May 30, 2026, to May 29, 2027.